Volume 11, Number 11—November 2005
Research
Neutralizing Antibody Response and SARS Severity
Mei-Shang Ho*, Wei-Ju Chen*, Hour-Young Chen†, Szu-Fong Lin†, Min-Chin Wang†, Jiali Di†, Yen-Ta Lu‡, Ching-Lung Liu‡, Shan-Chwen Chang§, Chung-Liang Chao¶, Chwan-Chuen King§, Jeng-Min Chiou*, Ih-Jen Su#, and Jyh-Yuan Yang†
Table 4
Seronegative rate of SARS-CoV patients, by source of infection*
| Source of infection | Total no. | Seronegative rate, n (%) |
|---|---|---|
| Known | 8/212 (3.7) | |
| Hospital-associated | ||
| Patient† | 81 | 3/44 (6.8) |
| Patient's close contacts | 55 | 1/43 (2.3) |
| Healthcare worker | 82 | 2/71 (3.1) |
| Other worker‡ | 27 | 1/19 (4.0) |
| Family and social contacts | 43 | 1/35 (2.9) |
| Unknown | 23/51 (45.1) | |
| Imported | 22 | 11/20 (55.0) |
| Indigenous | 36 | 12/31 (38.7) |
*Seronegative rates of the 2 groups with known and unknown source of infection were significantly different (χ2, p<0.10–7).
†In-hospital patients experiencing nosocomial SARS infection.
‡Including laundry workers, cleaners, clerks, and ambulance drivers.
Page created: February 17, 2012
Page updated: February 17, 2012
Page reviewed: February 17, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.